Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, and Preliminary Efficacy of Intra-Articular Injection of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Non-Traumatic Avascular Necrosis of the Femoral Head: A Single-Arm, Open-Label, Dose-Escalation Clinical Trial

NCT07787923 is registered in ClinicalTrials.gov with Beijing Jishuitan Hospital as lead sponsor.

NCT NCT07787923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07787923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, and Preliminary Efficacy of Intra-Articular Injection of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Non-Traumatic Avascular Necrosis of the Femoral Head: A Single-Arm, Open-Label, Dose-Escalation Clinical Trial
Lead sponsor
Beijing Jishuitan Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
May 31, 2028
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non traumatic osteonecrosis of the femoral head (hip)